Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00660
|
|||||
| Drug Name |
Novobiocin
|
|||||
| Synonyms |
(3R,4S,5R,6R)-5-hydroxy-6-{[4-hydroxy-3-({[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]carbonyl}amino)-8-methyl-2-oxo-2H-chromen-7-yl]oxy}-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate; (3r,4s,5r,6r)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]amino}-8-methyl-4-oxo-4h-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyltetrahydro-2h-pyran-4-yl carbamate(non-preferred name); 7-(3-(O-Carbamoyl)-4-(O-methyl)-5,5-dimethyl-alpha-L-lyxopyranosyloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamidol)-8-methylcumarin; 7-(Carbamoyltetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamide)-8-methyl-2H-chromen-2-one; Albamix; Albamycin; Albamycin (TN); Antibiotic PA-93; Cardelmycin; Cathocin; Cathomycin; Crystallinic acid; Inamycin; N-[7-[[3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-.beta.-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl); NOV; Novo-R; Novobiocin [INN:BAN]; Novobiocin sodium salt; Novobiocina; Novobiocina [INN-Spanish]; Novobiocine; Novobiocine [INN-French]; Novobiocinum; Novobiocinum [INN-Latin]; PA 93; Robiocina; Sirbiocina; Spheromycin; Stilbiocina; Streptonivicin; Streptonivicin (*Sodium salt*); U 6391; [(3R,4S,5R,6R)-5-hydroxy-6-[2-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-4-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C31H36N2O11
|
|||||
| Canonical SMILES |
CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O
|
|||||
| InChI |
InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1
|
|||||
| InChIKey |
YJQPYGGHQPGBLI-KGSXXDOSSA-N
|
|||||
| CAS Number |
CAS 303-81-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 612.6 | Topological Polar Surface Area | 196 | ||
| Heavy Atom Count | 44 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 11 | |||
| XLogP |
3.3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
